AI assistant
Sending…
COGNITION THERAPEUTICS INC — Director's Dealing 2021
Oct 8, 2021
34027_dirs_2021-10-07_3a77a502-5354-4ce8-880e-79e68d828a9b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COGNITION THERAPEUTICS INC (CGTX)
CIK: 0001455365
Period of Report: 2021-10-07
Reporting Person: Monia Brett P (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $1.2 | 2030-10-22 | Common Stock (41737) | Direct |
Footnotes
F1: The option vests in four (4) equal annual installments beginning on the first anniversary of the option's grant date. The option was granted on October 22, 2020.
More from COGNITION THERAPEUTICS INC
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
Mar 26
Annual Report
2026
Mar 26
Earnings Release
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 5